A growing number of reports have identified mutations in one allele of NPC1 in patients diagnosed with PD, parkinsonism or atypical PD, such as progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD) [46, 64–66]. Here, NPC1 is linked to Parkinson disease.